Trial Profile
Multicentre, controlled, prospective, randomized, open-label clinical trial to compare enteric-coated mycophenolate sodium (EC-MPS) plus reduced dose cyclosporine microemulsion (CsA-ME) vs EC-MPS plus standard dose CsA-ME in elderly de novo renal transplant recipients treated with basiliximab and short-term steroids.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Feb 2011
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Basiliximab; Ciclosporin; Corticosteroids
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 17 Dec 2005 New trial record.